Cristina Larkin

Overview

Cristina Larkin received an average of $1M in total compensation, including $395K in salary, at Spero Therapeutics from 2017 to 2021.

Source: SEC filings on August 5, 2022 and April 26, 2019.

Related executives

We found six more executives who work or worked at Spero Therapeutics.

Ankit Mahadevia

Spero Therapeutics

Chief Executive Officer

Satyavrat Shukla

Spero Therapeutics

Chief Executive Officer

Tamara Joseph

Spero Therapeutics

Chief Legal Officer

Christina Larkin

Spero Therapeutics

Chief Operating Officer

David Melnick

Spero Therapeutics

Chief Medical Officer

Joel Sendek

Spero Therapeutics

Chief Financial Officer

News

You may also like